Thursday, July 10, 2008

Novartis buys Speedel


Novartis has acquired a majority of shares in Swiss pharmaceutical maker Speedel Holding AG. It plans to acquire the remaining shares of Speedel through a mandatory public tender offer.

Speedel and Novartis jointly developed the high blood pressure drug Tekturna, which is known as Rasilez outside of the United States.

Go Alice go!

No comments: